BabyFormula

Reckitt Benckiser Shares Soar After Legal Triumph in Baby Formula Case

2 months ago

In a remarkable turn of events, shares of Reckitt Benckiser jumped an impressive 10.9% following a significant legal victory related to its baby formula products. This surge not only reflects the market's confidence in the company but also underscores the potential resolution of uncertainties surrounding its operations in the highly competitive baby nutrition sector.

Abbott and Reckitt Unit Exonerated in Baby Formula Trial: A Landmark Decision

2 months ago

In a significant legal outcome, a federal jury has acquitted both Abbott Laboratories and a unit of Reckitt Benckiser of any liability linked to the controversial baby formula linked to a tragic case involving the death of an infant due to bacterial infections. The jury deliberated for over four hours before reaching a unanimous verdict, clearing the companies of negligence claims in a trial that underscored the intense scrutiny surrounding infant nutrition products.

Reckitt's Strong Sales Provide Resilience Amid U.S. Baby Formula Litigation

2 months ago

In the face of ongoing legal challenges regarding its baby formula products, Reckitt Benckiser Group has reported a modest decline in sales, showcasing the company’s ability to navigate a turbulent landscape. Recent disclosures from the consumer goods giant reveal a 1.5% decrease in underlying sales for the third quarter of 2023, largely attributed to its infant nutrition sector, which has been significantly impacted by lawsuits across the United States.